Red Cedar Capital’s Elevance Health ELV Stock Holding History

Red Cedar Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$3.53M	Hold	6,880	–	–	2.24%	14
2022 Q3	$3.13M	Hold	6,880	–	–	2.16%	16
2022 Q2	$3.32M	Hold	6,880	–	–	2.25%	15
2022 Q1	$3.38M	Hold	6,880	–	–	2.04%	15
2021 Q4	$3.19M	Hold	6,880	–	–	1.82%	16
2021 Q3	$2.56M	Hold	6,880	–	–	1.57%	18
2021 Q2	$2.63M	Hold	6,880	–	–	1.65%	18
2021 Q1	$2.47M	Hold	6,880	–	–	1.65%	18
2020 Q4	$2.21M	Hold	6,880	–	–	1.61%	18
2020 Q3	$1.85M	Hold	6,880	–	–	1.61%	18
2020 Q2	$1.81M	Hold	6,880	–	–	1.64%	16
2020 Q1	$1.56M	Hold	6,880	–	–	1.57%	18
2019 Q4	$2.08M	Hold	6,880	–	–	1.58%	21
2019 Q3	$1.65M	Hold	6,880	–	–	1.36%	21
2019 Q2	$1.94M	Hold	6,880	–	–	1.64%	19
2019 Q1	$1.97M	Hold	6,880	–	–	1.68%	19
2018 Q4	$1.81M	Sell	6,880 -186	-3%	-$51.1K	1.75%	19
2018 Q3	$1.94M	Hold	7,066	–	–	1.7%	19
2018 Q2	$1.68M	Sell	7,066 -25	-0.4%	-$5.79K	1.52%	20
2018 Q1	$1.56M	Hold	7,091	–	–	1.41%	22
2017 Q4	$1.6M	Buy	+7,091	New	+$1.51M	1.34%	23

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Red Cedar Capital's ELV Position: Q4 2022 in Review

Red Cedar Capital held its Elevance Health (ELV) position steady in Q4 2022 at 6,880 shares worth $3.53M. The position accounts for 2.24% of the portfolio, ranked #14.

Red Cedar Capital first reported a position in ELV in Q4 2017 and has held it in 21 quarters since. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

Red Cedar Capital held 6,880 shares of Elevance Health worth $3.53M as of Q4 2022.
Red Cedar Capital left its Elevance Health share count unchanged in Q4 2022.
Elevance Health made up 2.24% of Red Cedar Capital's portfolio in Q4 2022, its #14 holding.
Red Cedar Capital first reported a position in Elevance Health in Q4 2017 and has held it in 21 quarters since.
1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.